P-49 Phase II study of epirubicin in combination with...

Lung Cancer 2003 / 8 Vol. 41

P-49 Phase II study of epirubicin in combination with weekly taxotere for patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based chemotherapy

Chang, John W.C., Tsao, Thomas C.Y., Chen, Chih-Hung, Tsai, Ying-Hwang, Lin, Meng-Chi, Lin, Chi-Ming
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
41
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(03)92018-6
Date:
August, 2003
File:
PDF, 169 KB
english, 2003
Conversion to is in progress
Conversion to is failed